Fig. 5

(a) Egg hatching rates in the treated and control site and their 95% lower and upper credible limits, (b) boosted sterile male competitiveness index and its 95% lower and upper credible limits, and (c) boosted sterile-to-wild males ratio, recorded during a boosted SIT trial in Vravrona, Attica Region, Greece, from May to November 2023. Note: The estimated value of competitiveness index during the fourth period of exposure was associated with a high ratio between sterile and wild males, therefore this value is omitted.